Search

Displaying results 9571 - 9580 of 10000 in total
  1. Drug

    Minodronic acid

    go.drugbank.com/drugs/DB06548
    Investigational

  2. Drug

    Atiprimod

    go.drugbank.com/drugs/DB05513
    Investigational

    Synonyms: 2-AZASPIRO(4.5)DECANE-2-PROPANAMINE N,N-DIETHYL-8,8-DIPROPYL-, N,N-Diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine
  3. Drug

    Declopramide

    go.drugbank.com/drugs/DB06421
    Experimental

  4. Drug

    TH0318

    go.drugbank.com/drugs/DB05145
    Experimental

    TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the treatment of type 2 diabetes.

  5. Drug

    Anisomycin

    go.drugbank.com/drugs/DB07374
    Experimental

    Anisomycin (sometimes known as flagecidin), is an antibiotic retrieved from the bacteria _Streptomyces griseolus_. This drug acts to inhibit bacterial protein and DNA synthesis.

  6. Drug

    Trifluoroethanol

    go.drugbank.com/drugs/DB03226
    Experimental

    It is also used in various pharmaceutical, chemical and engineering applications.

  7. Drug

    Ilorasertib

    go.drugbank.com/drugs/DB11694
    Investigational

    Ilorasertib has been used in trials studying the treatment of Myelodysplasia, Solid Neoplasm, Advanced Cancers, Advanced Solid Tumors, and Acute Myelogenous Leukemia, among others.

    Synonyms: Urea, N-(4-(4-amino-7-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)thieno(3,2-c)pyridin-3-yl)phenyl)-N'-(3-fluorophenyl)-
  8. Drug

    Peficitinib

    go.drugbank.com/drugs/DB11708
    Investigational

    Peficitinib has been used in trials studying the treatment and basic science of Psoriasis, Pharmacodynamics, Drug Interactions, Colitis, Ulcerative, and RHEUMATOID ARTHRITIS, among others.

  9. Drug

    Tanzisertib

    go.drugbank.com/drugs/DB11798
    Investigational

    Tanzisertib has been used in trials studying the treatment of Fibrosis, Discoid Lupus, Pulmonary Fibrosis, Interstitial Lung Disease, and Lung Diseases, Interstitial, among others.

  10. Drug

    PF-05180999

    go.drugbank.com/drugs/DB14885
    Investigational

    PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).